Your browser doesn't support javascript.
loading
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies.
Karim, Marwah; Saul, Sirle; Ghita, Luca; Sahoo, Malaya Kumar; Ye, Chengjin; Bhalla, Nishank; Lo, Chieh-Wen; Jin, Jing; Park, Jun-Gyu; Martinez-Gualda, Belén; East, Michael Patrick; Johnson, Gary L; Pinsky, Benjamin A; Martinez-Sobrido, Luis; Asquith, Christopher R M; Narayanan, Aarthi; De Jonghe, Steven; Einav, Shirit.
Afiliação
  • Karim M; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, CA, USA.
  • Saul S; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, CA, USA.
  • Ghita L; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, CA, USA.
  • Sahoo MK; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Ye C; Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Bhalla N; National Center for Biodefence and Infectious Disease, Biomedical Research Laboratory, School of Systems Biology, George Mason University, Manassas, VA, USA.
  • Lo CW; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, CA, USA.
  • Jin J; Vitalant Research Institute, San Francisco, CA, USA.
  • Park JG; Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Martinez-Gualda B; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
  • East MP; Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
  • Johnson GL; Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC, 27599, USA.
  • Pinsky BA; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, CA, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Asquith CRM; Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, 70211, Finland.
  • Narayanan A; National Center for Biodefence and Infectious Disease, Biomedical Research Laboratory, School of Systems Biology, George Mason University, Manassas, VA, USA.
  • De Jonghe S; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
  • Einav S; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, CA, USA; Department of Microbiology and Immunology, Stanford University, CA, USA; Chan Zuckerberg Biohub, San Francisco, CA, 94158, USA. Electronic address: seinav@stanford.edu.
Antiviral Res ; 204: 105367, 2022 08.
Article em En | MEDLINE | ID: mdl-35738348
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Antiviral Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Antiviral Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos